Mammalian target of rapamycin inhibition induces cell cycle arrest in diffuse large B cell lymphoma (DLBCL) cells and sensitises DLBCL cells to rituximab
β Scribed by Kathrin Wanner; Susanne Hipp; Madlene Oelsner; Ingo Ringshausen; Christian Bogner; Christian Peschel; Thomas Decker
- Book ID
- 108673876
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 818 KB
- Volume
- 134
- Category
- Article
- ISSN
- 0007-1048
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract HTLVβIβassociated adult Tβcell leukemia/lymphoma (ATL) and human Tβcell lymphotropic virus type I (HTLVβI)βnegative peripheral Tβcell lymphomas carry poor prognosis mainly because of acquired resistance to chemotherapy. We have shown that this disease is responsive to the combination of
## Abstract Our study explored the drug interaction of allβ__tran__s retinoic acid (ATRA) and RAD001 (everolimus), the inhibitor of mammalian target of rapamycin complex 1 (mTORC1), in acute myelogenous leukemia (AML) NB4 and HL60 cells. RAD001 (10 nM) significantly enhanced the ATRAβinduced growth